We can develop various new drugs that are not limited to specific diseases or target proteins.
Our core drug discovery technology, the "RiboART (Ribomic Aptamer Refined Therapeutics) System," is built on comprehensive technologies, knowledge, and experience related to aptamer drug discovery, establishing a platform (drug discovery foundation) that can be universally applied to the creation of new drug candidates. By using the "RiboART System," it is possible to develop various new drugs that are not limited to specific diseases or target proteins. Please feel free to contact us if you have any inquiries. 【Features of Aptamer Pharmaceuticals】 ■ Strong target binding ability ■ Few restrictions on targets ■ Easy chemical modifications ■ Production through chemical synthesis ■ Low antigenicity *For more details, please download the PDF or contact us.
Inquire About This Product
basic information
For more details, please download the PDF or contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or contact us.
catalog（1）
Download All Catalogs
Company information
Our company is engaged in drug discovery business utilizing the drug discovery technology "RiboART System" to develop various new drugs that are not limited to specific diseases or target proteins. This drug discovery business consists of two components: in-house drug discovery and collaborative research with other pharmaceutical companies. For some drug candidates, we will conduct clinical trials in-house and, after obtaining Proof of Concept (POC), we will license them out to pharmaceutical companies.
![[Market Report] Global Diabetic Nephropathy Market](https://image.mono.ipros.com/public/product/image/c4d/2001085036/IPROS44903853150834469168.jpeg?w=280&h=280)
![[Research Material] The Global Market for Infertility Treatment](https://image.mono.ipros.com/public/product/image/ae6/2001467175/IPROS35452704149680769661.jpeg?w=280&h=280)
![[Research Material] Global Market for Treatment of Head Lice Infestation](https://image.mono.ipros.com/public/product/image/609/2001467525/IPROS50826046643529000810.jpeg?w=280&h=280)
